Patents by Inventor Anli Zhang

Anli Zhang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SEQUENTIAL TREATMENT OF CANCERS USING 6-THIO-dG, CHECKPOINT INHIBITORS AND RADIATION THERAPY
    Publication number: 20240424013
    Abstract: Disclosed herein are methods of treatments with a telomerase-mediated telomere-targeting drug, 6-thio-2?-deoxyguanosine (6-thio-dG), checkpoint inhibitors and/or radiation therapy for treating cancers. eads to tumor regression in innate and adaptive immune-dependent manners in syngeneic and humanized mouse cancer models.
    Type: Application
    Filed: September 9, 2024
    Publication date: December 26, 2024
    Applicant: The Board of Regents of The University of Texas System
    Inventors: Jerry SHAY, Yang-Xin FU, Ilgen MENDER, Anli ZHANG
  • Sequential treatment of cancers using 6-thio-dG, checkpoint inhibitors and radiation therapy
    Patent number: 12097213
    Abstract: Disclosed herein are methods of treatments with a telomerase-mediated telomere-targeting drug, 6-thio-2?-deoxyguanosine (6-thio-dG), checkpoint inhibitors and/or radiation therapy for treating cancers. Leads to tumor regression in innate and adaptive immune-dependent manners in syngeneic and humanized mouse cancer models.
    Type: Grant
    Filed: March 12, 2021
    Date of Patent: September 24, 2024
    Assignee: The Board of Regents of The University of Texas System
    Inventors: Jerry Shay, Yang-Xin Fu, Ilgen Mender, Anli Zhang
  • SEQUENTIAL TREATMENT OF CANCERS USING 6-THIO-dG, CHECKPOINT INHIBITORS AND RADIATION THERAPY
    Publication number: 20210290652
    Abstract: Disclosed herein are methods of treatments with a telomerase-mediated telomere-targeting drug, 6-thio-2?-deoxyguanosine (6-thio-dG), checkpoint inhibitors and/or radiation therapy for treating cancers. eads to tumor regression in innate and adaptive immune-dependent manners in syngeneic and humanized mouse cancer models.
    Type: Application
    Filed: March 12, 2021
    Publication date: September 23, 2021
    Applicant: The Board of Regents of the University of Texas System
    Inventors: Jerry Shay, Yang-Xin Fu, Ilgen Mender, Anli Zhang